Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771108 · ClinicalTrials.gov registry record · NA
Exercise Dose and Nonalcoholic Fatty Liver Disease
A NA study of Non-Alcoholic Fatty Liver Disease (NAFLD), sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT00771108 is a NA study of Non-Alcoholic Fatty Liver Disease (NAFLD) that has completed, run by Washington University School of Medicine. The registered enrollment target is 33 participants, below the 68-participant average among 6 other Non-Alcoholic Fatty Liver Disease (NAFLD) trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00771108, a NA study of Non-Alcoholic Fatty Liver Disease (NAFLD), has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to provide a better understanding of how exercise (walking) affects non-alcoholic fatty liver disease (NAFLD) in overweight people. NAFLD, which is common in obese people, occurs when the liver has too much fat.
Conditions Studied
Interventions
- BEHAVIORAL exercise
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2006-05 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771108
The ClinicalTrials.gov registry entry for NCT00771108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 68-participant average among 6 other Non-Alcoholic Fatty Liver Disease (NAFLD) trials with a reported enrollment target (51% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Alcoholic Fatty Liver Disease (NAFLD) appearing as the primary indexed condition, and to 1 intervention - of which exercise is the first listed.
NCT00771108 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00771108 about?
NCT00771108 is a clinical study titled "Exercise Dose and Nonalcoholic Fatty Liver Disease". The purpose of this research is to provide a better understanding of how exercise (walking) affects non-alcoholic fatty liver disease (NAFLD) in overweight people. NAFLD, which is common in obese people, occurs when the liver has too much fat.
What is the current status of trial NCT00771108?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2006-05. Estimated completion is 2011-04.
What conditions does trial NCT00771108 study?
This clinical trial studies the following conditions: Non-Alcoholic Fatty Liver Disease (NAFLD).
What interventions are being tested in trial NCT00771108?
The interventions under investigation include: exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00771108?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00771108 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Alcoholic Fatty Liver Disease (NAFLD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
RECRUITING · NA
-
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
ACTIVE NOT RECRUITING · NA
-
Regulation of FGF21 by Nutritional Challenges
COMPLETED · NA
-
Milk Thistle Clinical Trial in Pediatric NAFLD
RECRUITING · Phase 2
-
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
RECRUITING · Phase 1
-
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.